HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Serum amyloid A is a better predictive biomarker of mucosal healing than C-reactive protein in ulcerative colitis in clinical remission.

AbstractBACKGROUND:
Many studies have revealed that mucosal healing improves the long-term prognosis of ulcerative colitis. Frequent colonoscopy is difficult because of its invasiveness and cost. Therefore, in diagnosing and treating ulcerative colitis, noninvasive, low-cost methods for predicting mucosal healing using useful biomarkers are required in the clinical setting. This study aimed to evaluate whether serum amyloid A is a better serum biomarker than C-reactive protein in predicting mucosal healing in ulcerative colitis patients in clinical remission.
METHODS:
Ulcerative colitis patients whose C-reactive protein and serum amyloid A were measured within 1 month before and after colonoscopy were included in this retrospective study, and the relationship between the C-reactive protein and serum amyloid A values and the mucosal condition was analyzed. Mucosal condition was assessed using the Mayo Endoscopic Score, with score 0 or 1 indicating mucosal healing.
RESULTS:
A total of 199 colonoscopic examinations were conducted in 108 ulcerative colitis patients who underwent C-reactive protein and serum amyloid A blood tests. In clinical remission patients, serum amyloid A showed a strong correlation with mucosal inflammation compared to C-reactive protein and had excellent sensitivity and specificity rates with significant statistical significance.
CONCLUSIONS:
Serum amyloid A is a more useful marker compared to C-reactive protein in predicting mucosal inflammation in ulcerative colitis patients in clinical remission.
AuthorsMasaki Wakai, Ryohei Hayashi, Shinji Tanaka, Toshikatsu Naito, Junko Kumada, Motonobu Nomura, Hidehiko Takigawa, Shiro Oka, Yoshitaka Ueno, Masanori Ito, Kazuaki Chayama
JournalBMC gastroenterology (BMC Gastroenterol) Vol. 20 Issue 1 Pg. 85 (Apr 03 2020) ISSN: 1471-230X [Electronic] England
PMID32245401 (Publication Type: Journal Article)
Chemical References
  • Adrenal Cortex Hormones
  • Anti-Inflammatory Agents, Non-Steroidal
  • Biological Products
  • Biomarkers
  • Immunologic Factors
  • Serum Amyloid A Protein
  • Mesalamine
  • C-Reactive Protein
Topics
  • Adolescent
  • Adrenal Cortex Hormones (therapeutic use)
  • Adult
  • Aged
  • Anti-Inflammatory Agents, Non-Steroidal (therapeutic use)
  • Biological Products (therapeutic use)
  • Biomarkers (metabolism)
  • C-Reactive Protein (metabolism)
  • Child
  • Colitis, Ulcerative (drug therapy, metabolism, pathology)
  • Colonoscopy
  • Female
  • Humans
  • Immunologic Factors (therapeutic use)
  • Intestinal Mucosa (pathology)
  • Male
  • Mesalamine (therapeutic use)
  • Middle Aged
  • Remission Induction
  • Serum Amyloid A Protein (metabolism)
  • Severity of Illness Index
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: